SIBN
Price
$15.73
Change
+$0.37 (+2.41%)
Updated
Sep 13 closing price
50 days until earnings call
TNDM
Price
$43.97
Change
+$0.21 (+0.48%)
Updated
Sep 13 closing price
45 days until earnings call
Ad is loading...

SIBN vs TNDM

Header iconSIBN vs TNDM Comparison
Open Charts SIBN vs TNDMBanner chart's image
SI-BONE
Price$15.73
Change+$0.37 (+2.41%)
Volume$151.11K
CapitalizationN/A
Tandem Diabetes Care
Price$43.97
Change+$0.21 (+0.48%)
Volume$994.81K
CapitalizationN/A
View a ticker or compare two or three
SIBN vs TNDM Comparison Chart
Loading...
SIBN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
SIBN vs. TNDM commentary
Sep 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SIBN is a StrongBuy and TNDM is a Buy.

COMPARISON
Comparison
Sep 15, 2024
Stock price -- (SIBN: $15.73 vs. TNDM: $43.97)
Brand notoriety: SIBN and TNDM are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SIBN: 47% vs. TNDM: 69%
Market capitalization -- SIBN: $672.23M vs. TNDM: $2.32B
SIBN [@Medical Specialties] is valued at $672.23M. TNDM’s [@Medical Specialties] market capitalization is $2.32B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SIBN’s FA Score shows that 0 FA rating(s) are green whileTNDM’s FA Score has 0 green FA rating(s).

  • SIBN’s FA Score: 0 green, 5 red.
  • TNDM’s FA Score: 0 green, 5 red.
According to our system of comparison, SIBN is a better buy in the long-term than TNDM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SIBN’s TA Score shows that 5 TA indicator(s) are bullish while TNDM’s TA Score has 5 bullish TA indicator(s).

  • SIBN’s TA Score: 5 bullish, 5 bearish.
  • TNDM’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, TNDM is a better buy in the short-term than SIBN.

Price Growth

SIBN (@Medical Specialties) experienced а +3.83% price change this week, while TNDM (@Medical Specialties) price change was +3.70% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +5.47%. For the same industry, the average monthly price growth was +6.61%, and the average quarterly price growth was -1.85%.

Reported Earning Dates

SIBN is expected to report earnings on Nov 04, 2024.

TNDM is expected to report earnings on Oct 30, 2024.

Industries' Descriptions

@Medical Specialties (+5.47% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNDM($2.32B) has a higher market cap than SIBN($672M). TNDM YTD gains are higher at: 48.648 vs. SIBN (-25.060). SIBN has higher annual earnings (EBITDA): -34.45M vs. TNDM (-196.97M). TNDM has more cash in the bank: 468M vs. SIBN (166M). SIBN has less debt than TNDM: SIBN (39M) vs TNDM (416M). TNDM has higher revenues than SIBN: TNDM (748M) vs SIBN (139M).
SIBNTNDMSIBN / TNDM
Capitalization672M2.32B29%
EBITDA-34.45M-196.97M17%
Gain YTD-25.06048.648-52%
P/E RatioN/A666.67-
Revenue139M748M19%
Total Cash166M468M35%
Total Debt39M416M9%
FUNDAMENTALS RATINGS
SIBN vs TNDM: Fundamental Ratings
SIBN
TNDM
OUTLOOK RATING
1..100
7167
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
4739
P/E GROWTH RATING
1..100
10092
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIBN's Valuation (46) in the Medical Specialties industry is somewhat better than the same rating for TNDM (98). This means that SIBN’s stock grew somewhat faster than TNDM’s over the last 12 months.

SIBN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as TNDM (100). This means that SIBN’s stock grew similarly to TNDM’s over the last 12 months.

SIBN's SMR Rating (95) in the Medical Specialties industry is in the same range as TNDM (97). This means that SIBN’s stock grew similarly to TNDM’s over the last 12 months.

TNDM's Price Growth Rating (39) in the Medical Specialties industry is in the same range as SIBN (47). This means that TNDM’s stock grew similarly to SIBN’s over the last 12 months.

TNDM's P/E Growth Rating (92) in the Medical Specialties industry is in the same range as SIBN (100). This means that TNDM’s stock grew similarly to SIBN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SIBNTNDM
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
68%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 7 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
73%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
N/A
View a ticker or compare two or three
Ad is loading...
SIBN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSCYX9.610.27
+2.89%
Victory RS Small Cap Equity Y
HWAIX39.910.42
+1.06%
Hotchkis & Wiley Value Opps Instl
EQPIX37.850.32
+0.85%
Fidelity Advisor Equity Income I
PEIQX42.670.31
+0.73%
Principal Equity Income R5
TNBIX19.400.07
+0.37%
1290 SmartBeta Equity I

SIBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with KIDS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then KIDS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
+2.41%
KIDS - SIBN
51%
Loosely correlated
+2.15%
FNA - SIBN
47%
Loosely correlated
+0.68%
QTRX - SIBN
44%
Loosely correlated
+2.64%
LUNG - SIBN
44%
Loosely correlated
+1.59%
UTMD - SIBN
42%
Loosely correlated
+3.23%
More

TNDM and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNDM has been loosely correlated with NVRO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TNDM jumps, then NVRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNDM
1D Price
Change %
TNDM100%
+0.48%
NVRO - TNDM
41%
Loosely correlated
+13.53%
PODD - TNDM
39%
Loosely correlated
+1.48%
XRAY - TNDM
36%
Loosely correlated
+3.51%
MMSI - TNDM
35%
Loosely correlated
+0.19%
LMAT - TNDM
34%
Loosely correlated
+1.71%
More